ZEUGMA XR 500 MG COM REV LIB PROL CT FR PLAS PEAD OPC X 100
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1256803400059 -
GGREM
528524110204504 -
Código de barras
7899547549676
O que a fonte publica
- Detentor do registro
- PRATI DONADUZZI & CIA LTDA
- Princípios ativos
- DIVALPROATO DE SÓDIO
- Embalagem
- 500 MG COM REV LIB PROL CT FR PLAS PEAD OPC X 100
- Regime de dispensação
- Tarja Vermelha sob restrição
- Tipo de produto
- Similar
- Classe terapêutica
- N3A - ANTIEPILÉPTICOS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "ZEUGMA XR 500 MG COM REV LIB PROL CT FR PLAS PEAD OPC X 100",
"holder": "PRATI DONADUZZI & CIA LTDA",
"stripe": "Tarja Vermelha sob restrição",
"barcodes": [
"7899547549676"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "528524110204504",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "73.856.593/0001-66",
"priceRegime": "Regulado",
"productName": "ZEUGMA XR",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "500 MG COM REV LIB PROL CT FR PLAS PEAD OPC X 100",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha sob restrição",
"factoryPrices": {
"icms-0": "322.92",
"icms-12": "366.95",
"icms-17": "389.06",
"icms-18": "393.80",
"icms-19": "398.67",
"icms-20": "403.65",
"icms-21": "408.76",
"icms-22": "414.00",
"icms-23": "419.38",
"icms-17.5": "391.42",
"icms-19.5": "401.14",
"icms-20.5": "406.19",
"icms-22.5": "416.67",
"icms-12-alc": "362.55",
"icms-17-alc": "384.39",
"icms-18-alc": "389.08",
"icms-19-alc": "393.88",
"icms-20-alc": "398.81",
"icms-21-alc": "403.85",
"icms-22-alc": "409.03",
"icms-23-alc": "414.34",
"withoutTaxes": "319.04",
"icms-17.5-alc": "386.72",
"icms-19.5-alc": "396.33",
"icms-20.5-alc": "401.31",
"icms-22.5-alc": "411.67"
},
"pisCofinsList": "Positiva",
"substanceText": "DIVALPROATO DE SÓDIO",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "445.11",
"icms-12": "505.80",
"icms-17": "536.28",
"icms-18": "542.81",
"icms-19": "549.53",
"icms-20": "556.39",
"icms-21": "563.43",
"icms-22": "570.66",
"icms-23": "578.07",
"icms-17.5": "539.53",
"icms-19.5": "552.93",
"icms-20.5": "559.89",
"icms-22.5": "574.34",
"icms-12-alc": "501.20",
"icms-17-alc": "531.40",
"icms-18-alc": "537.88",
"icms-19-alc": "544.52",
"icms-20-alc": "551.33",
"icms-21-alc": "558.30",
"icms-22-alc": "565.46",
"icms-23-alc": "572.80",
"withoutTaxes": "441.06",
"icms-17.5-alc": "534.62",
"icms-19.5-alc": "547.90",
"icms-20.5-alc": "554.79",
"icms-22.5-alc": "569.11"
},
"invalidBarcodes": [],
"activeSubstances": [
"DIVALPROATO DE SÓDIO"
],
"therapeuticClass": "N3A - ANTIEPILÉPTICOS",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1256803400059",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "N3A",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:528524110204504"